Good morning from the Financial Times.
Today is Thursday, August 20th, and this is your FT News Briefing.
The U.S. Treasury is hoping to calm the bond sell-off,
and Moderna's stock price got a booster after some positive trial results.
Plus, U.S. Law firms are using a controversial recruiting practice.
I'm Sonia Hudson, InfoMark Filipino, and here's the news you need to start your day.
U.S.
Treasury is trying to contain a bond sell-off in order to keep borrowing costs from rising further.
It announced yesterday it would at least double purchases of long-term government debt.
But will that strategy work?
Here to tell us is the FT's Claire Jones.
Hi, Claire.
Hi, Sonia.
Can you explain the Treasury's thinking here?
Why would buying government debt help limit the sell-off?
So coming into this surprise move, as you say,
we've seen quite a big sell-off at the long end of the US Treasury market.
We've seen longer term bonds, which are particularly important for the government's borrowing costs and also household
and businesses borrowing costs, rise in quite heavily over recent weeks.
What the US Treasury said it was going to do in a surprise announcement on Wednesday morning was say that it would...